Yesterday, on the 7th of september Mark Offerhaus held a pitch on the Making Waves event. It regarded endolysin technology, a technology highly similar to phage technology used in PhageGuard. Endolysins are the enzymes produced by Phages. We were voted the best Dutch innovation. The Netherlands delegates Micreos with the … Continue reading →

In the wake of the problems associated with increasing antimicrobial resistance, scientists have now developed the first effective alternative to antibiotics in a significant advance in the fight against drug-resistant infection. Here, Bjorn Herpers looks at the promise of endolysins. It is easy to become numb to stories we frequently … Continue reading →